{
    "medicine_id": "c3769c15c86326a9df81cdb803e3210cb2c7e4a4",
    "platform_id": "DB01356",
    "metadata": {
        "name": "Amytal Sodium 0 5 g 5mL Injection powder lyophilized for solution",
        "composition": "0 5 g 5mL Lithium cation",
        "clinical_particulars": {
            "therapeutic_indications": "Lithium in its salt forms is used as a mood stabilizer and for the treatment of depression and mania It is most frequently prescribed in the treatment of bipolar disorder",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Although lithium has been used for over 50 years in treatment of bipolar disorder the mechanism of action is still unknown Lithium s therapeutic action may be due to a number of effects ranging from inhibition of enzymes such as glycogen synthase kinase 3 inositol phosphatases or modulation of glutamate receptors",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00921",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "Hydrocodone may increase the central nervous system depressant CNS depressant activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Lithium cation can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Lithium cation may increase the sedative activities of Pramipexole"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Lithium cation may increase the sedative activities of Ropinirole"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Lithium cation may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "Lithium cation may increase the antipsychotic activities of Amisulpride"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Methylphenidate"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of adverse effects can be increased when Metoclopramide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "The risk or severity of adverse effects can be increased when Metyrosine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09097",
                        "description": "The therapeutic efficacy of Quinagolide can be decreased when used in combination with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "Lithium cation may increase the antipsychotic activities of Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "Lithium hydroxide may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "Lithium citrate may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01071",
                        "description": "Lithium cation may increase the arrhythmogenic activities of Mequitazine"
                    },
                    {
                        "drugbank-id": "DB04844",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tetrabenazine"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Deutetrabenazine"
                    },
                    {
                        "drugbank-id": "DB00529",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Foscarnet"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "Tenofovir disoproxil may increase the nephrotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "Tenofovir alafenamide may increase the nephrotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "Tenofovir may increase the nephrotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Lithium cation may increase the serotonergic activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when Sertraline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Nefazodone"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Lithium cation may increase the serotonergic activities of Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00229",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefotiam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00267",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefmenoxime is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00274",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00430",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00447",
                        "description": "The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00456",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefalotin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00493",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefotaxime is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of nephrotoxicity can be increased when Methotrexate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00626",
                        "description": "The risk or severity of nephrotoxicity can be increased when Bacitracin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00689",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cephaloglycin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00718",
                        "description": "The risk or severity of nephrotoxicity can be increased when Adefovir dipivoxil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "The risk or severity of nephrotoxicity can be increased when Acyclovir is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefaclor is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of nephrotoxicity can be increased when Tacrolimus is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00923",
                        "description": "The risk or severity of nephrotoxicity can be increased when Ceforanide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of nephrotoxicity can be increased when Carboplatin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01066",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefditoren is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The risk or severity of nephrotoxicity can be increased when Atazanavir is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01111",
                        "description": "The risk or severity of nephrotoxicity can be increased when Colistimethate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01112",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefuroxime is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01139",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefapirin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefadroxil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01150",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefprozil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "The risk or severity of nephrotoxicity can be increased when Ceftriaxone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01326",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefamandole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01327",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01328",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefonicid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01329",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefoperazone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefotetan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01331",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefoxitin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01332",
                        "description": "The risk or severity of nephrotoxicity can be increased when Ceftizoxime is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "The risk or severity of nephrotoxicity can be increased when Cefradine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01413",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefepime"
                    },
                    {
                        "drugbank-id": "DB01414",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefacetrile"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Ceftibuten"
                    },
                    {
                        "drugbank-id": "DB01416",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefpodoxime"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Phenazopyridine"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB02247",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Hydrolyzed Cephalothin"
                    },
                    {
                        "drugbank-id": "DB03450",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cephalothin Group"
                    },
                    {
                        "drugbank-id": "DB04570",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Latamoxef"
                    },
                    {
                        "drugbank-id": "DB04918",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Ceftobiprole"
                    },
                    {
                        "drugbank-id": "DB06590",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Ceftaroline fosamil"
                    },
                    {
                        "drugbank-id": "DB09008",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefaloridine"
                    },
                    {
                        "drugbank-id": "DB09062",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefminox"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefroxadine"
                    },
                    {
                        "drugbank-id": "DB11935",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Flomoxef"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Brincidofovir"
                    },
                    {
                        "drugbank-id": "DB13266",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefatrizine"
                    },
                    {
                        "drugbank-id": "DB13461",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefcapene"
                    },
                    {
                        "drugbank-id": "DB13470",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefodizime"
                    },
                    {
                        "drugbank-id": "DB13499",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefsulodin"
                    },
                    {
                        "drugbank-id": "DB13504",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefetamet"
                    },
                    {
                        "drugbank-id": "DB13638",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefbuperazone"
                    },
                    {
                        "drugbank-id": "DB13667",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefozopran"
                    },
                    {
                        "drugbank-id": "DB13682",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefpirome"
                    },
                    {
                        "drugbank-id": "DB13778",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cefazedone"
                    },
                    {
                        "drugbank-id": "DB13821",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Ceftezole"
                    },
                    {
                        "drugbank-id": "DB13868",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Adefovir"
                    },
                    {
                        "drugbank-id": "DB14713",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Inotersen"
                    },
                    {
                        "drugbank-id": "DB15066",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Givosiran"
                    },
                    {
                        "drugbank-id": "DB00452",
                        "description": "The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01421",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Paromomycin"
                    },
                    {
                        "drugbank-id": "DB04263",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Geneticin"
                    },
                    {
                        "drugbank-id": "DB04626",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Apramycin"
                    },
                    {
                        "drugbank-id": "DB04808",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Neamine"
                    },
                    {
                        "drugbank-id": "DB08437",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Puromycin"
                    },
                    {
                        "drugbank-id": "DB11512",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Dihydrostreptomycin"
                    },
                    {
                        "drugbank-id": "DB11520",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Hygromycin B"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of nephrotoxicity can be increased when Icosapent is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of nephrotoxicity can be increased when Indomethacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of nephrotoxicity can be increased when Rofecoxib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of nephrotoxicity can be increased when Piroxicam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of nephrotoxicity can be increased when Fenoprofen is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of nephrotoxicity can be increased when Diclofenac is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of nephrotoxicity can be increased when Sulindac is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "The risk or severity of nephrotoxicity can be increased when Furosemide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of nephrotoxicity can be increased when Flurbiprofen is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of nephrotoxicity can be increased when Etodolac is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of nephrotoxicity can be increased when Mefenamic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of nephrotoxicity can be increased when Naproxen is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of nephrotoxicity can be increased when Sulfasalazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of nephrotoxicity can be increased when Phenylbutazone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of nephrotoxicity can be increased when Meloxicam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of nephrotoxicity can be increased when Carprofen is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of nephrotoxicity can be increased when Diflunisal is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of nephrotoxicity can be increased when Bumetanide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of nephrotoxicity can be increased when Etacrynic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of nephrotoxicity can be increased when Salicylic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of nephrotoxicity can be increased when Meclofenamic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of nephrotoxicity can be increased when Acetylsalicylic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of nephrotoxicity can be increased when Balsalazide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of nephrotoxicity can be increased when Ibuprofen is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of nephrotoxicity can be increased when Olsalazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lumiracoxib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Magnesium salicylate"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Salsalate"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Choline magnesium trisalicylate"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Antrafenine"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Aminophenazone"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Tiaprofenic acid"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Oxyphenbutazone"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Nimesulide"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Benoxaprofen"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Metamizole"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Zomepirac"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Cimicoxib"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Lornoxicam"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Aceclofenac"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Zaltoprofen"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Azapropazone"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Parecoxib"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Salicylamide"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Kebuzone"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Isoxicam"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Indoprofen"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Ibuproxam"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Floctafenine"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Fenbufen"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Etofenamate"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Epirizole"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Benzydamine"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Loxoprofen"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Dexibuprofen"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Dexketoprofen"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Droxicam"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Tolfenamic acid"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Firocoxib"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Clonixin"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Morniflumate"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Propacetamol"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Talniflumate"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Robenacoxib"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Flunixin"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Nitroaspirin"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Indobufen"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Tinoridine"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Alclofenac"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Fentiazac"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Suxibuzone"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Bumadizone"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Alminoprofen"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Difenpiramide"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Nifenazone"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Lonazolac"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Tenidap"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Propyphenazone"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Proglumetacin"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Guacetisal"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Ethenzamide"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Carbaspirin calcium"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Mofebutazone"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Proquazone"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Benorilate"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Pirprofen"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Acemetacin"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with Imidazole salicylate"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with SC 236"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of nephrotoxicity can be increased when Lithium cation is combined with NS 398"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Metixene"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Profenamine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Biperiden"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Revefenacin"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Timepidium"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Benzatropine"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Maprotiline"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Tolterodine"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Promethazine"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Doxepin"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Desipramine"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Tiotropium"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Aclidinium"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Gallamine triethiodide"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Lamotrigine"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Rocuronium"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Lithium cation may increase the central nervous system depressant CNS depressant activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The risk or severity of adverse effects can be increased when Lorpiprazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Acetophenazine"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Bifeprunox"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Lumateperone"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The risk or severity of adverse effects can be increased when Tenamfetamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Lithium cation may decrease the stimulatory activities of Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "Lithium cation may decrease the stimulatory activities of Phentermine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "Lithium cation may decrease the stimulatory activities of Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "Lithium cation may decrease the stimulatory activities of Benzphetamine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "Lithium cation may decrease the stimulatory activities of Diethylpropion"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "Lithium cation may decrease the stimulatory activities of Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "Lithium cation may decrease the stimulatory activities of Mephentermine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "Lithium cation may decrease the stimulatory activities of MMDA"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "Lithium cation may decrease the stimulatory activities of Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "Lithium cation may decrease the stimulatory activities of 2 5 Dimethoxy 4 ethylamphetamine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "Lithium cation may decrease the stimulatory activities of 4 Bromo 2 5 dimethoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "Lithium cation may decrease the stimulatory activities of Chlorphentermine"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "Lithium cation may decrease the stimulatory activities of Methylenedioxyethamphetamine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "Lithium cation may decrease the stimulatory activities of Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "Lithium cation may decrease the stimulatory activities of Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "Lithium cation may decrease the stimulatory activities of Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "Lithium cation may decrease the stimulatory activities of Ritobegron"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "Lithium cation may decrease the stimulatory activities of Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "Lithium cation may decrease the stimulatory activities of Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "Lithium cation may decrease the stimulatory activities of Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "Lithium cation may decrease the stimulatory activities of 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "The risk or severity of QTc prolongation can be increased when Goserelin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00218",
                        "description": "The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "The risk or severity of QTc prolongation can be increased when Ranolazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00263",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluorouracil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00556",
                        "description": "The risk or severity of QTc prolongation can be increased when Perflutren is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "The risk or severity of QTc prolongation can be increased when Propranolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "The risk or severity of QTc prolongation can be increased when Atropine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of QTc prolongation can be increased when Efavirenz is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00640",
                        "description": "The risk or severity of QTc prolongation can be increased when Adenosine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of QTc prolongation can be increased when Carbinoxamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of QTc prolongation can be increased when Dolasetron is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "The risk or severity of QTc prolongation can be increased when Roxithromycin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00779",
                        "description": "The risk or severity of QTc prolongation can be increased when Nalidixic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00827",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinoxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of QTc prolongation can be increased when Granisetron is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of QTc prolongation can be increased when Levosimendan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of QTc prolongation can be increased when Desloratadine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "The risk or severity of QTc prolongation can be increased when Telithromycin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00978",
                        "description": "The risk or severity of QTc prolongation can be increased when Lomefloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of QTc prolongation can be increased when Dimenhydrinate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01087",
                        "description": "The risk or severity of QTc prolongation can be increased when Primaquine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of QTc prolongation can be increased when Papaverine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "The risk or severity of QTc prolongation can be increased when Levofloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01155",
                        "description": "The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of QTc prolongation can be increased when Propafenone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01195",
                        "description": "The risk or severity of QTc prolongation can be increased when Flecainide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The risk or severity of QTc prolongation can be increased when Clarithromycin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of QTc prolongation can be increased when Saquinavir is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxprenolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01599",
                        "description": "The risk or severity of QTc prolongation can be increased when Probucol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB02638",
                        "description": "The risk or severity of QTc prolongation can be increased when Terlipressin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB04957",
                        "description": "The risk or severity of QTc prolongation can be increased when Azimilide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB05223",
                        "description": "The risk or severity of QTc prolongation can be increased when Pracinostat is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB05488",
                        "description": "The risk or severity of QTc prolongation can be increased when Technetium Tc 99m ciprofloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06160",
                        "description": "The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06200",
                        "description": "The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06334",
                        "description": "The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "The risk or severity of QTc prolongation can be increased when Telavancin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06600",
                        "description": "The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08799",
                        "description": "The risk or severity of QTc prolongation can be increased when Antazoline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The risk or severity of QTc prolongation can be increased when Crizotinib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08903",
                        "description": "The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The risk or severity of QTc prolongation can be increased when Ceritinib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "The risk or severity of QTc prolongation can be increased when Lenvatinib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09555",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine maleate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11640",
                        "description": "The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11830",
                        "description": "The risk or severity of QTc prolongation can be increased when Mocetinostat is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11841",
                        "description": "The risk or severity of QTc prolongation can be increased when Entinostat is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12174",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 101 is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12286",
                        "description": "The risk or severity of QTc prolongation can be increased when Simendan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12376",
                        "description": "The risk or severity of QTc prolongation can be increased when Ricolinostat is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12523",
                        "description": "The risk or severity of QTc prolongation can be increased when Mizolastine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12565",
                        "description": "The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12877",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13261",
                        "description": "The risk or severity of QTc prolongation can be increased when Sitafloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13546",
                        "description": "The risk or severity of QTc prolongation can be increased when Nizofenone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13652",
                        "description": "The risk or severity of QTc prolongation can be increased when Bunaftine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13653",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorcainide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13679",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexchlorpheniramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The risk or severity of QTc prolongation can be increased when Ivosidenib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of QTc prolongation can be increased when Indenolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of QTc prolongation can be increased when Promazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The risk or severity of QTc prolongation can be increased when Mesoridazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Melperone"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Sultopride"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of QTc prolongation can be increased when Pentamidine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Imipramine"
                    },
                    {
                        "drugbank-id": "DB11718",
                        "description": "The risk or severity of QTc prolongation can be increased when Encorafenib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01084",
                        "description": "The risk or severity of QTc prolongation can be increased when Emedastine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The risk or severity of QTc prolongation can be increased when Diltiazem is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of QTc prolongation can be increased when Cinnarizine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The risk or severity of QTc prolongation can be increased when Loperamide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "The risk or severity of QTc prolongation can be increased when Nifedipine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of QTc prolongation can be increased when Mibefradil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of QTc prolongation can be increased when Prenylamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of QTc prolongation can be increased when Nilvadipine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of QTc prolongation can be increased when Fendiline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of QTc prolongation can be increased when Benidipine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexverapamil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB15982",
                        "description": "The risk or severity of QTc prolongation can be increased when Berotralstat is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00104",
                        "description": "The risk or severity of QTc prolongation can be increased when Octreotide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00107",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of QTc prolongation can be increased when Esmolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "The risk or severity of QTc prolongation can be increased when Nelfinavir is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "The risk or severity of QTc prolongation can be increased when Buclizine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00467",
                        "description": "The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00487",
                        "description": "The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The risk or severity of QTc prolongation can be increased when Ritonavir is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The risk or severity of QTc prolongation can be increased when Amodiaquine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of QTc prolongation can be increased when Tamoxifen is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of QTc prolongation can be increased when Moricizine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The risk or severity of QTc prolongation can be increased when Tizanidine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibandronate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of QTc prolongation can be increased when Apomorphine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00719",
                        "description": "The risk or severity of QTc prolongation can be increased when Azatadine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00817",
                        "description": "The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of QTc prolongation can be increased when Propofol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00920",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00927",
                        "description": "The risk or severity of QTc prolongation can be increased when Famotidine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of QTc prolongation can be increased when Salmeterol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of QTc prolongation can be increased when Felbamate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The risk or severity of QTc prolongation can be increased when Formoterol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01044",
                        "description": "The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of QTc prolongation can be increased when Norfloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of QTc prolongation can be increased when Diphenhydramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01106",
                        "description": "The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of QTc prolongation can be increased when Itraconazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of QTc prolongation can be increased when Desflurane is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01228",
                        "description": "The risk or severity of QTc prolongation can be increased when Encainide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of QTc prolongation can be increased when Alimemazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The risk or severity of QTc prolongation can be increased when Dasatinib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The risk or severity of QTc prolongation can be increased when Digitoxin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01426",
                        "description": "The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01620",
                        "description": "The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB04576",
                        "description": "The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB04695",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The risk or severity of QTc prolongation can be increased when Celiprolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB05465",
                        "description": "The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06217",
                        "description": "The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06468",
                        "description": "The risk or severity of QTc prolongation can be increased when Cariporide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06663",
                        "description": "The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06699",
                        "description": "The risk or severity of QTc prolongation can be increased when Degarelix is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06719",
                        "description": "The risk or severity of QTc prolongation can be increased when Buserelin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06788",
                        "description": "The risk or severity of QTc prolongation can be increased when Histrelin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06825",
                        "description": "The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB07780",
                        "description": "The risk or severity of QTc prolongation can be increased when Farnesyl diphosphate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB07841",
                        "description": "The risk or severity of QTc prolongation can be increased when Geranylgeranyl diphosphate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of QTc prolongation can be increased when Bupranolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "The risk or severity of QTc prolongation can be increased when Rilpivirine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of QTc prolongation can be increased when Eribulin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The risk or severity of QTc prolongation can be increased when Dabrafenib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08936",
                        "description": "The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08972",
                        "description": "The risk or severity of QTc prolongation can be increased when Flumequine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11390",
                        "description": "The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11397",
                        "description": "The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11408",
                        "description": "The risk or severity of QTc prolongation can be increased when Famphur is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11412",
                        "description": "The risk or severity of QTc prolongation can be increased when Fenthion is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11443",
                        "description": "The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11448",
                        "description": "The risk or severity of QTc prolongation can be increased when Phosmet is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11491",
                        "description": "The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11511",
                        "description": "The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11591",
                        "description": "The risk or severity of QTc prolongation can be increased when Bilastine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11614",
                        "description": "The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The risk or severity of QTc prolongation can be increased when Ebastine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of QTc prolongation can be increased when Talinolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11774",
                        "description": "The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11891",
                        "description": "The risk or severity of QTc prolongation can be increased when CUDC 907 is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11892",
                        "description": "The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12231",
                        "description": "The risk or severity of QTc prolongation can be increased when Temefos is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12245",
                        "description": "The risk or severity of QTc prolongation can be increased when Triclabendazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12645",
                        "description": "The risk or severity of QTc prolongation can be increased when Givinostat is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13358",
                        "description": "The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13555",
                        "description": "The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13627",
                        "description": "The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13651",
                        "description": "The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13744",
                        "description": "The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13772",
                        "description": "The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13823",
                        "description": "The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of QTc prolongation can be increased when Levomenthol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "The risk or severity of QTc prolongation can be increased when Fluconazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "The risk or severity of QTc prolongation can be increased when Timolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00674",
                        "description": "The risk or severity of QTc prolongation can be increased when Galantamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of QTc prolongation can be increased when Amantadine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of QTc prolongation can be increased when Sulfamethoxazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The risk or severity of QTc prolongation can be increased when Cilostazol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The risk or severity of QTc prolongation can be increased when Mirabegron is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "The risk or severity of QTc prolongation can be increased when Clofazimine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "The risk or severity of QTc prolongation can be increased when Isradipine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of QTc prolongation can be increased when Losartan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of QTc prolongation can be increased when Moexipril is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "The risk or severity of QTc prolongation can be increased when Indapamide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00916",
                        "description": "The risk or severity of QTc prolongation can be increased when Metronidazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "The risk or severity of QTc prolongation can be increased when Felodipine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11853",
                        "description": "The risk or severity of QTc prolongation can be increased when Relugolix is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of adverse effects can be increased when Bromocriptine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Levetiracetam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "The risk or severity of adverse effects can be increased when Eletriptan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Enflurane is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of adverse effects can be increased when Methysergide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of adverse effects can be increased when Cabergoline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Methocarbamol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Metharbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when Entacapone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Oxycodone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Mephenytoin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Mazindol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be increased when Lisuride is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Butorphanol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Paramethadione is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Dyclonine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Pentazocine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The risk or severity of adverse effects can be increased when Ergotamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Sufentanil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Procaine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Meclizine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when Riluzole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of adverse effects can be increased when Scopolamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of adverse effects can be increased when Ethotoin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when Clidinium is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The risk or severity of adverse effects can be increased when Propiomazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Alfentanil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Phensuximide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Levorphanol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of adverse effects can be increased when Alprenolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Remifentanil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Tiagabine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Hexafluronium is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "The risk or severity of adverse effects can be increased when Naratriptan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The risk or severity of adverse effects can be increased when Alosetron is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "The risk or severity of adverse effects can be increased when Frovatriptan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when Melatonin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Vigabatrin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Methyprylon is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Phenacemide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Halothane is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Procarbazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be increased when Pergolide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Oxymorphone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Dezocine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when Dantrolene is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of adverse effects can be increased when Levodopa is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Decamethonium is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The risk or severity of adverse effects can be increased when Ergometrine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when St John s Wort is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when Aprobarbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Butobarbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Heptabarbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Glutethimide"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with gamma Hydroxybutyric acid"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Camazepam"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dichloralphenazone"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Difenoxin"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Delorazepam"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Chlorhexadol"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Drotebanol"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cloxazolam"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Clotiazepam"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Quazepam"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cinolazepam"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Alverine"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with S Ethylisothiourea"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Domoic Acid"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Valpromide"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Methapyrilene"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Nomifensine"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Urethane"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Methaqualone"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cilansetron"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pagoclone"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Flibanserin"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Renzapride"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with APD791"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tetrodotoxin"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Naronapride"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Naluzotan"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with PRX 08066"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tolperisone"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Clomethiazole"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tramiprosate"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ocinaplon"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Gaboxadol"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Agomelatine"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Saredutant"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Nitrous oxide"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Fospropofol"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Triclofos"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Mebutamate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cinitapride"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Xylazine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Romifidine"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Detomidine"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Piclozotan"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Donepezil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Gabapentin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Lorazepam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Reserpine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Temazepam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when Atomoxetine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The risk or severity of adverse effects can be increased when Etomidate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when Pentobarbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Codeine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Tolcapone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Hydromorphone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when Cetirizine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The risk or severity of adverse effects can be increased when Clobazam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Palonosetron is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Alprazolam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when Secobarbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Meperidine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when Metaxalone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "The risk or severity of adverse effects can be increased when Sumatriptan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Midazolam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Flurazepam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of adverse effects can be increased when Phenelzine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Fentanyl is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Diazepam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Oxazepam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Triazolam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The risk or severity of adverse effects can be increased when Almotriptan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "The risk or severity of adverse effects can be increased when Rizatriptan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "The risk or severity of adverse effects can be increased when Pindolol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Zaleplon is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when Ramelteon is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The risk or severity of adverse effects can be increased when Guanfacine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Clonazepam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of adverse effects can be increased when Bupropion is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Estazolam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of adverse effects can be increased when Ketamine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Penbutolol"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Rasagiline"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Bromazepam"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Lorcaserin"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Brivaracetam"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Gabapentin enacarbil"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tasimelteon"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tiapride"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Solriamfetol"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when Succinylcholine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when Butalbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of adverse effects can be increased when Phenytoin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of adverse effects can be increased when Topiramate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of adverse effects can be increased when Trimethadione is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of adverse effects can be increased when Methohexital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Cisatracurium is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of adverse effects can be increased when Ethosuximide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when Thiopental is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Furazolidone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when Primidone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Acetazolamide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Zonisamide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of adverse effects can be increased when Thiamylal is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of adverse effects can be increased when Phenobarbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Tubocurarine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The risk or severity of adverse effects can be increased when Fosphenytoin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Vecuronium is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when Amobarbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Hexobarbital is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pargyline"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The risk or severity of QTc prolongation can be increased when Dofetilide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of QTc prolongation can be increased when Anagrelide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "The risk or severity of QTc prolongation can be increased when Disopyramide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of QTc prolongation can be increased when Clemastine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "The risk or severity of QTc prolongation can be increased when Ibutilide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The risk or severity of QTc prolongation can be increased when Terfenadine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00365",
                        "description": "The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of QTc prolongation can be increased when Quinine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of QTc prolongation can be increased when Sotalol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The risk or severity of QTc prolongation can be increased when Erlotinib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00539",
                        "description": "The risk or severity of QTc prolongation can be increased when Toremifene is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of QTc prolongation can be increased when Cisapride is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of QTc prolongation can be increased when Imatinib is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The risk or severity of QTc prolongation can be increased when Astemizole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00685",
                        "description": "The risk or severity of QTc prolongation can be increased when Trovafloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The risk or severity of QTc prolongation can be increased when Mifepristone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of QTc prolongation can be increased when Cocaine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of QTc prolongation can be increased when Arsenic trioxide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The risk or severity of QTc prolongation can be increased when Domperidone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01208",
                        "description": "The risk or severity of QTc prolongation can be increased when Sparfloxacin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01405",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Temafloxacin"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Romidepsin"
                    },
                    {
                        "drugbank-id": "DB06697",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Artemether"
                    },
                    {
                        "drugbank-id": "DB06708",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Lumefantrine"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Eliglustat"
                    },
                    {
                        "drugbank-id": "DB09083",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Ivabradine"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Ribociclib"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Glasdegib"
                    },
                    {
                        "drugbank-id": "DB13074",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Macimorelin"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of QTc prolongation can be increased when Thioridazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of QTc prolongation can be increased when Flupentixol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of QTc prolongation can be increased when Pimozide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of QTc prolongation can be increased when Paliperidone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Quinidine"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Procainamide"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of QTc prolongation can be increased when Amiodarone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of QTc prolongation can be increased when Bepridil is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Lithium cation can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Olanzapine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when Protriptyline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Meprobamate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Loxapine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The risk or severity of adverse effects can be increased when Remoxipride is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The risk or severity of adverse effects can be increased when Triflupromazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The risk or severity of adverse effects can be increased when Nortriptyline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of adverse effects can be increased when Amoxapine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Adinazolam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The risk or severity of adverse effects can be increased when Fluphenazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of adverse effects can be increased when Trimipramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Risperidone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Halazepam is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Minaprine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Progabide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The risk or severity of adverse effects can be increased when Perphenazine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of adverse effects can be increased when Selegiline is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Moclobemide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Chlormezanone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be increased when Aripiprazole is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The risk or severity of adverse effects can be increased when Chlorprothixene is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Bufotenine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Fencamfamin"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ethyl loflazepate"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cathinone"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Fludiazepam"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Prazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Nitrazepam"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Molindone"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Rolipram"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with 7 Nitroindazole"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Oxitriptan"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Phencyclidine"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Phenethylamine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Aniracetam"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Amineptine"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Osanetant"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Adipiplon"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dextofisopam"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Vilazodone"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Perospirone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Azaperone"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Perazine"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Benperidol"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB11637",
                        "description": "Lithium cation may increase the QTc prolonging activities of Delamanid"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Lithium cation can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB00399",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lithium cation is combined with Zoledronic acid"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lithium cation is combined with Alendronic acid"
                    },
                    {
                        "drugbank-id": "DB00720",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lithium cation is combined with Clodronic acid"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lithium cation is combined with Risedronic acid"
                    },
                    {
                        "drugbank-id": "DB01077",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lithium cation is combined with Etidronic acid"
                    },
                    {
                        "drugbank-id": "DB06255",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lithium cation is combined with Incadronic acid"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "The risk or severity of nephrotoxicity and hypocalcemia can be increased when Lithium cation is combined with Tiludronic acid"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "Lithium cation may decrease the excretion rate of Aldesleukin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "Lithium cation may decrease the excretion rate of Daptomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "Lithium cation may decrease the excretion rate of Tositumomab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "Lithium cation may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Lithium cation may decrease the excretion rate of Folic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00165",
                        "description": "Lithium cation may decrease the excretion rate of Pyridoxine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "Lithium cation may decrease the excretion rate of Cevimeline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "Lithium cation may decrease the excretion rate of Carbidopa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "Lithium cation may decrease the excretion rate of Oseltamivir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00200",
                        "description": "Lithium cation may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "Lithium cation may decrease the excretion rate of Ticlopidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Lithium cation may decrease the excretion rate of Pantoprazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00225",
                        "description": "Lithium cation may decrease the excretion rate of Gadodiamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Lithium cation may decrease the excretion rate of Milrinone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "Lithium cation may decrease the excretion rate of Doxycycline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "Lithium cation may decrease the excretion rate of Carmustine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Lithium cation may decrease the excretion rate of Metoprolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00271",
                        "description": "Lithium cation may decrease the excretion rate of Diatrizoate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Lithium cation may decrease the excretion rate of Liothyronine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Lithium cation may decrease the excretion rate of Acarbose which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Lithium cation may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "Lithium cation may decrease the excretion rate of Bleomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Lithium cation may decrease the excretion rate of Etonogestrel which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "Lithium cation may decrease the excretion rate of Ropivacaine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00303",
                        "description": "Lithium cation may decrease the excretion rate of Ertapenem which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Lithium cation may decrease the excretion rate of Acetaminophen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "Lithium cation may decrease the excretion rate of Piperacillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "Lithium cation may decrease the excretion rate of Floxuridine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Lithium cation may decrease the excretion rate of Nitroprusside which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Lithium cation may decrease the excretion rate of Ethambutol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Lithium cation may decrease the excretion rate of Metformin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00339",
                        "description": "Lithium cation may decrease the excretion rate of Pyrazinamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Lithium cation may decrease the excretion rate of Megestrol acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00355",
                        "description": "Lithium cation may decrease the excretion rate of Aztreonam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "Lithium cation may decrease the excretion rate of Sulfadiazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Lithium cation may decrease the excretion rate of Sucralfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "Lithium cation may decrease the excretion rate of Dexrazoxane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "Lithium cation may decrease the excretion rate of Rosiglitazone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "Lithium cation may decrease the excretion rate of Ampicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "Lithium cation may decrease the excretion rate of Trifluridine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "Lithium cation may decrease the excretion rate of Nitric Oxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Lithium cation may decrease the excretion rate of Allopurinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "Lithium cation may decrease the excretion rate of Trimethoprim which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "Lithium cation may decrease the excretion rate of Gemcitabine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "Lithium cation may decrease the excretion rate of Lenalidomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "Lithium cation may decrease the excretion rate of Buspirone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "Lithium cation may decrease the excretion rate of Flutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "Lithium cation may decrease the excretion rate of Cimetidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "Lithium cation may decrease the excretion rate of Cefdinir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00548",
                        "description": "Lithium cation may decrease the excretion rate of Azelaic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "Lithium cation may decrease the excretion rate of Methoxsalen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00558",
                        "description": "Lithium cation may decrease the excretion rate of Zanamivir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "Lithium cation may decrease the excretion rate of Fondaparinux which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "Lithium cation may decrease the excretion rate of Levocarnitine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "Lithium cation may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00597",
                        "description": "Lithium cation may decrease the excretion rate of Gadoteridol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Lithium cation may decrease the excretion rate of Labetalol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Lithium cation may decrease the excretion rate of Medroxyprogesterone acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Lithium cation may decrease the excretion rate of Bisoprolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Lithium cation may decrease the excretion rate of Testosterone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Lithium cation may decrease the excretion rate of Clofarabine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "Lithium cation may decrease the excretion rate of Prednisone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Lithium cation may decrease the excretion rate of Mecamylamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Lithium cation may decrease the excretion rate of Nilutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Lithium cation may decrease the excretion rate of Chlorpropamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Lithium cation may decrease the excretion rate of Mycophenolate mofetil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Lithium cation may decrease the excretion rate of Phentolamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Lithium cation may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "Lithium cation may decrease the excretion rate of Tamsulosin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Lithium cation may decrease the excretion rate of Lamivudine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "Lithium cation may decrease the excretion rate of Oxacillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00716",
                        "description": "Lithium cation may decrease the excretion rate of Nedocromil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "Lithium cation may decrease the excretion rate of Thiabendazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Lithium cation may decrease the excretion rate of Nateglinide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00733",
                        "description": "Lithium cation may decrease the excretion rate of Pralidoxime which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Lithium cation may decrease the excretion rate of Tetracycline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00760",
                        "description": "Lithium cation may decrease the excretion rate of Meropenem which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "Lithium cation may decrease the excretion rate of Potassium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "Lithium cation may decrease the excretion rate of Methimazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "Lithium cation may decrease the excretion rate of Tirofiban which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Lithium cation may decrease the excretion rate of Estradiol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00789",
                        "description": "Lithium cation may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Lithium cation may decrease the excretion rate of Fenoldopam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Lithium cation may decrease the excretion rate of Ribavirin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Lithium cation may decrease the excretion rate of Tadalafil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00828",
                        "description": "Lithium cation may decrease the excretion rate of Fosfomycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Lithium cation may decrease the excretion rate of Tolazamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Lithium cation may decrease the excretion rate of Dobutamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "Lithium cation may decrease the excretion rate of Dacarbazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "Lithium cation may decrease the excretion rate of Temozolomide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "Lithium cation may decrease the excretion rate of Ranitidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "Lithium cation may decrease the excretion rate of Emtricitabine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "Lithium cation may decrease the excretion rate of Testolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Lithium cation may decrease the excretion rate of Didanosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Lithium cation may decrease the excretion rate of Tinidazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "Lithium cation may decrease the excretion rate of Azacitidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "Lithium cation may decrease the excretion rate of Isoniazid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "Lithium cation may decrease the excretion rate of Mepivacaine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Lithium cation may decrease the excretion rate of Methyldopa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Lithium cation may decrease the excretion rate of Dopamine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "Lithium cation may decrease the excretion rate of Azathioprine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00995",
                        "description": "Lithium cation may decrease the excretion rate of Auranofin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "Lithium cation may decrease the excretion rate of Levobupivacaine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "Lithium cation may decrease the excretion rate of Ganciclovir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Lithium cation may decrease the excretion rate of Edrophonium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "Lithium cation may decrease the excretion rate of Metyrapone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Lithium cation may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01022",
                        "description": "Lithium cation may decrease the excretion rate of Phylloquinone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Lithium cation may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "Lithium cation may decrease the excretion rate of Topotecan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "Lithium cation may decrease the excretion rate of Probenecid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "Lithium cation may decrease the excretion rate of Fenofibrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Lithium cation may decrease the excretion rate of Memantine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "Lithium cation may decrease the excretion rate of Lubiprostone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01048",
                        "description": "Lithium cation may decrease the excretion rate of Abacavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "Lithium cation may decrease the excretion rate of Amoxicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Lithium cation may decrease the excretion rate of Glipizide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "Lithium cation may decrease the excretion rate of Dimethyl sulfoxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "Lithium cation may decrease the excretion rate of Flucytosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "Lithium cation may decrease the excretion rate of Capecitabine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "Lithium cation may decrease the excretion rate of Tolbutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Lithium cation may decrease the excretion rate of Rabeprazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "Lithium cation may decrease the excretion rate of Trimetrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Lithium cation may decrease the excretion rate of Guanethidine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "Lithium cation may decrease the excretion rate of Ifosfamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "Lithium cation may decrease the excretion rate of Naloxone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Lithium cation may decrease the excretion rate of Nadolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01205",
                        "description": "Lithium cation may decrease the excretion rate of Flumazenil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01213",
                        "description": "Lithium cation may decrease the excretion rate of Fomepizole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "Lithium cation may decrease the excretion rate of Budesonide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Lithium cation may decrease the excretion rate of Epoprostenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "Lithium cation may decrease the excretion rate of Gemfibrozil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01249",
                        "description": "Lithium cation may decrease the excretion rate of Iodixanol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "Lithium cation may decrease the excretion rate of Sitagliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "Lithium cation may decrease the excretion rate of Varenicline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Lithium cation may decrease the excretion rate of Hydralazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "Lithium cation may decrease the excretion rate of Colchicine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Lithium cation may decrease the excretion rate of Testosterone propionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "Lithium cation may decrease the excretion rate of Amrinone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01428",
                        "description": "Lithium cation may decrease the excretion rate of Oxybenzone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Lithium cation may decrease the excretion rate of Allylestrenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01550",
                        "description": "Lithium cation may decrease the excretion rate of Fenproporex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "Lithium cation may decrease the excretion rate of Valganciclovir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "Lithium cation may decrease the excretion rate of Sorbitol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Lithium cation may decrease the excretion rate of Roflumilast which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Lithium cation may decrease the excretion rate of Topiroxostat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Lithium cation may decrease the excretion rate of Estrone sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "Lithium cation may decrease the excretion rate of Pegaptanib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05018",
                        "description": "Lithium cation may decrease the excretion rate of Migalastat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "Lithium cation may decrease the excretion rate of Apremilast which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06154",
                        "description": "Lithium cation may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "Lithium cation may decrease the excretion rate of Ipilimumab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "Lithium cation may decrease the excretion rate of Icatibant which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Lithium cation may decrease the excretion rate of Alogliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "Lithium cation may decrease the excretion rate of Prasugrel which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "Lithium cation may decrease the excretion rate of Doripenem which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Lithium cation may decrease the excretion rate of Rivaroxaban which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "Lithium cation may decrease the excretion rate of Nalmefene which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Lithium cation may decrease the excretion rate of Droxidopa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Lithium cation may decrease the excretion rate of Saxagliptin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "Lithium cation may decrease the excretion rate of Prucalopride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06623",
                        "description": "Lithium cation may decrease the excretion rate of Flupirtine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "Lithium cation may decrease the excretion rate of Dalfampridine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Lithium cation may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06705",
                        "description": "Lithium cation may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "Lithium cation may decrease the excretion rate of Methyltestosterone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "Lithium cation may decrease the excretion rate of Ammonium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06782",
                        "description": "Lithium cation may decrease the excretion rate of Dimercaprol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06796",
                        "description": "Lithium cation may decrease the excretion rate of Mangafodipir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Lithium cation may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06809",
                        "description": "Lithium cation may decrease the excretion rate of Plerixafor which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Lithium cation may decrease the excretion rate of Pralatrexate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06815",
                        "description": "Lithium cation may decrease the excretion rate of Pyrithione which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06823",
                        "description": "Lithium cation may decrease the excretion rate of Tiopronin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Lithium cation may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08824",
                        "description": "Lithium cation may decrease the excretion rate of Ioflupane I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Lithium cation may decrease the excretion rate of Deferiprone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "Lithium cation may decrease the excretion rate of N methylnicotinamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "Lithium cation may decrease the excretion rate of Ruxolitinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "Lithium cation may decrease the excretion rate of Peginesatide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "Lithium cation may decrease the excretion rate of Enzalutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08900",
                        "description": "Lithium cation may decrease the excretion rate of Teduglutide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "Lithium cation may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "Lithium cation may decrease the excretion rate of Formestane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "Lithium cation may decrease the excretion rate of Canagliflozin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "Lithium cation may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "Lithium cation may decrease the excretion rate of Trametinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Lithium cation may decrease the excretion rate of Macitentan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "Lithium cation may decrease the excretion rate of Sofosbuvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Lithium cation may decrease the excretion rate of Ledipasvir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "Lithium cation may decrease the excretion rate of Ceftolozane which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09066",
                        "description": "Lithium cation may decrease the excretion rate of Corifollitropin alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "Lithium cation may decrease the excretion rate of Edoxaban which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09081",
                        "description": "Lithium cation may decrease the excretion rate of Idebenone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "Lithium cation may decrease the excretion rate of Tixocortol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09103",
                        "description": "Lithium cation may decrease the excretion rate of Ancestim which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "Lithium cation may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09106",
                        "description": "Lithium cation may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09111",
                        "description": "Lithium cation may decrease the excretion rate of Pentastarch which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09121",
                        "description": "Lithium cation may decrease the excretion rate of Aurothioglucose which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Lithium cation may decrease the excretion rate of Dienogest which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09129",
                        "description": "Lithium cation may decrease the excretion rate of Chromic chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09132",
                        "description": "Lithium cation may decrease the excretion rate of Gadoteric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09133",
                        "description": "Lithium cation may decrease the excretion rate of Iothalamic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09134",
                        "description": "Lithium cation may decrease the excretion rate of Ioversol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09135",
                        "description": "Lithium cation may decrease the excretion rate of Ioxilan which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09136",
                        "description": "Lithium cation may decrease the excretion rate of Isosulfan blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "Lithium cation may decrease the excretion rate of Technetium Tc 99m mebrofenin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Lithium cation may decrease the excretion rate of Technetium Tc 99m oxidronate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09148",
                        "description": "Lithium cation may decrease the excretion rate of Florbetaben 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09149",
                        "description": "Lithium cation may decrease the excretion rate of Florbetapir 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09156",
                        "description": "Lithium cation may decrease the excretion rate of Iopromide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09163",
                        "description": "Lithium cation may decrease the excretion rate of Technetium Tc 99m exametazime which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09165",
                        "description": "Lithium cation may decrease the excretion rate of Technetium Tc 99m pyrophosphate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "Lithium cation may decrease the excretion rate of Arotinolol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Lithium cation may decrease the excretion rate of Moxisylyte which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09209",
                        "description": "Lithium cation may decrease the excretion rate of Pholcodine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09210",
                        "description": "Lithium cation may decrease the excretion rate of Piracetam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "Lithium cation may decrease the excretion rate of Bisoxatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Lithium cation may decrease the excretion rate of Nicorandil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "Lithium cation may decrease the excretion rate of Dextran which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "Lithium cation may decrease the excretion rate of Tegafur which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09257",
                        "description": "Lithium cation may decrease the excretion rate of Gimeracil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "Lithium cation may decrease the excretion rate of Idarucizumab which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Lithium cation may decrease the excretion rate of Lixisenatide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "Lithium cation may decrease the excretion rate of Picosulfuric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "Lithium cation may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Lithium cation may decrease the excretion rate of Choline C 11 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "Lithium cation may decrease the excretion rate of Magnesium trisilicate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Lithium cation may decrease the excretion rate of Sacubitril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09301",
                        "description": "Lithium cation may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Lithium cation may decrease the excretion rate of Synthetic Conjugated Estrogens A which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Lithium cation may decrease the excretion rate of Synthetic Conjugated Estrogens B which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "Lithium cation may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09324",
                        "description": "Lithium cation may decrease the excretion rate of Sulbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09325",
                        "description": "Lithium cation may decrease the excretion rate of Sodium fluoride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "Lithium cation may decrease the excretion rate of Antihemophilic Factor Recombinant PEGylated which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "Lithium cation may decrease the excretion rate of Mersalyl which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09344",
                        "description": "Lithium cation may decrease the excretion rate of Invert sugar which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09357",
                        "description": "Lithium cation may decrease the excretion rate of Dexpanthenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09394",
                        "description": "Lithium cation may decrease the excretion rate of Phosphoric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09395",
                        "description": "Lithium cation may decrease the excretion rate of Sodium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Lithium cation may decrease the excretion rate of Magnesium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "Lithium cation may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "Lithium cation may decrease the excretion rate of Sodium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Lithium cation may decrease the excretion rate of Enalaprilat which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "Lithium cation may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09496",
                        "description": "Lithium cation may decrease the excretion rate of Octinoxate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09502",
                        "description": "Lithium cation may decrease the excretion rate of Fludeoxyglucose 18F which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09546",
                        "description": "Lithium cation may decrease the excretion rate of Iobenguane sulfate I 123 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "Lithium cation may decrease the excretion rate of Ixazomib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "Lithium cation may decrease the excretion rate of Polyethylene glycol 400 which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "Lithium cation may decrease the excretion rate of Resorcinol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "Lithium cation may decrease the excretion rate of Potassium nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "Lithium cation may decrease the excretion rate of Potassium bicarbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11102",
                        "description": "Lithium cation may decrease the excretion rate of N acetyltyrosine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11114",
                        "description": "Lithium cation may decrease the excretion rate of Eucalyptus oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11121",
                        "description": "Lithium cation may decrease the excretion rate of Chloroxylenol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11127",
                        "description": "Lithium cation may decrease the excretion rate of Selenious acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "Lithium cation may decrease the excretion rate of Selenium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11136",
                        "description": "Lithium cation may decrease the excretion rate of Chromium which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11145",
                        "description": "Lithium cation may decrease the excretion rate of Oxyquinoline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11164",
                        "description": "Lithium cation may decrease the excretion rate of Bicisate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11251",
                        "description": "Lithium cation may decrease the excretion rate of Tocopherol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Lithium cation may decrease the excretion rate of DL Methylephedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11328",
                        "description": "Lithium cation may decrease the excretion rate of Tetradecyl hydrogen sulfate ester which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11338",
                        "description": "Lithium cation may decrease the excretion rate of Clove oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "Lithium cation may decrease the excretion rate of Evening primrose oil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11364",
                        "description": "Lithium cation may decrease the excretion rate of Pidotimod which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "Lithium cation may decrease the excretion rate of Lesinurad which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11577",
                        "description": "Lithium cation may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Lithium cation may decrease the excretion rate of Etafedrine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "Lithium cation may decrease the excretion rate of Antithrombin III human which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "Lithium cation may decrease the excretion rate of Naldemedine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "Lithium cation may decrease the excretion rate of Baricitinib which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "Lithium cation may decrease the excretion rate of Apalutamide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "Lithium cation may decrease the excretion rate of Valbenazine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11989",
                        "description": "Lithium cation may decrease the excretion rate of Benznidazole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12007",
                        "description": "Lithium cation may decrease the excretion rate of Isoflavone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12107",
                        "description": "Lithium cation may decrease the excretion rate of Vaborbactam which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "Lithium cation may decrease the excretion rate of Benserazide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "Lithium cation may decrease the excretion rate of Levosalbutamol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13156",
                        "description": "Lithium cation may decrease the excretion rate of Inosine pranobex which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13178",
                        "description": "Lithium cation may decrease the excretion rate of Inositol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13185",
                        "description": "Lithium cation may decrease the excretion rate of Oxabolone cipionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13191",
                        "description": "Lithium cation may decrease the excretion rate of Phosphocreatine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13269",
                        "description": "Lithium cation may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "Lithium cation may decrease the excretion rate of Ipecac which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Lithium cation may decrease the excretion rate of Almasilate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "Lithium cation may decrease the excretion rate of Fenofibric acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "Lithium cation may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Lithium cation may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "Lithium cation may decrease the excretion rate of Testosterone cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "Lithium cation may decrease the excretion rate of Testosterone enanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Lithium cation may decrease the excretion rate of Testosterone undecanoate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Lithium cation may decrease the excretion rate of Estradiol acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Lithium cation may decrease the excretion rate of Estradiol cypionate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Lithium cation may decrease the excretion rate of Estradiol dienanthate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Lithium cation may decrease the excretion rate of Estradiol valerate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "Lithium cation may decrease the excretion rate of Patent Blue which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "Lithium cation may decrease the excretion rate of Choline salicylate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14007",
                        "description": "Lithium cation may decrease the excretion rate of Pentetic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "Lithium cation may decrease the excretion rate of Potassium acetate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "Lithium cation may decrease the excretion rate of Potassium sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14526",
                        "description": "Lithium cation may decrease the excretion rate of Chromic citrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14527",
                        "description": "Lithium cation may decrease the excretion rate of Chromic nitrate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14528",
                        "description": "Lithium cation may decrease the excretion rate of Chromium gluconate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14529",
                        "description": "Lithium cation may decrease the excretion rate of Chromium nicotinate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14530",
                        "description": "Lithium cation may decrease the excretion rate of Chromous sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15593",
                        "description": "Lithium cation may decrease the excretion rate of Golodirsen which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13987",
                        "description": "Lithium cation may decrease the excretion rate of Strontium chloride which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "Lithium cation may decrease the excretion rate of Potassium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04890",
                        "description": "Lithium cation may decrease the excretion rate of Bepotastine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "Lithium cation may decrease the excretion rate of Isotretinoin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "Lithium cation may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Lithium cation may decrease the excretion rate of Desmopressin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Lithium cation may decrease the excretion rate of Nisoldipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Lithium cation may decrease the excretion rate of Fosinopril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Lithium cation may decrease the excretion rate of Metolazone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "Lithium cation may decrease the excretion rate of Dyphylline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "Lithium cation may decrease the excretion rate of Verapamil which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Lithium cation may decrease the excretion rate of Lisinopril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Lithium cation may decrease the excretion rate of Perindopril which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "Lithium cation may decrease the excretion rate of Pentoxifylline which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Lithium cation may decrease the excretion rate of Clevidipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "Lithium cation may decrease the excretion rate of Permethrin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "Lithium cation may decrease the excretion rate of Difluocortolone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "Lithium cation may decrease the excretion rate of Lithium carbonate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "Capreomycin may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "Vancomycin may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Cisplatin may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Lithium cation may decrease the excretion rate of Digoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "Lithium cation may decrease the excretion rate of Pemetrexed which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "Lithium cation may decrease the excretion rate of Warfarin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "Lithium cation may decrease the excretion rate of Plazomicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "Lithium cation may decrease the excretion rate of Pentostatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "Lithium cation may decrease the excretion rate of Nedaplatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00803",
                        "description": "Colistin may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Carbamazepine may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00479",
                        "description": "Amikacin may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00684",
                        "description": "Tobramycin may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00798",
                        "description": "Gentamicin may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00955",
                        "description": "Netilmicin may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01082",
                        "description": "Streptomycin may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01172",
                        "description": "Kanamycin may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03615",
                        "description": "Lithium cation may decrease the excretion rate of Ribostamycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04729",
                        "description": "Lithium cation may decrease the excretion rate of Gentamicin C1a which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06696",
                        "description": "Lithium cation may decrease the excretion rate of Arbekacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12604",
                        "description": "Lithium cation may decrease the excretion rate of Sisomicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13540",
                        "description": "Lithium cation may decrease the excretion rate of Isepamicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00311",
                        "description": "Ethoxzolamide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "Methazolamide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "Diclofenamide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06370",
                        "description": "Indisulam may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "Conivaptan may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Diazoxide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "Drospirenone may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Tienilic acid may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05034",
                        "description": "Ularitide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "Tolvaptan may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "Dapagliflozin may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "Potassium citrate may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09401",
                        "description": "Isosorbide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11827",
                        "description": "Ertugliflozin may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12670",
                        "description": "Rolofylline may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12704",
                        "description": "Spiradoline may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13284",
                        "description": "Meticrane may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13405",
                        "description": "Mefruside may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13617",
                        "description": "Clorexolone may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13663",
                        "description": "Clofenamide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13708",
                        "description": "Fenquizone may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13792",
                        "description": "Clopamide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Muzolimine may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Xipamide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "Potassium may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "Amiloride may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "Canrenoic acid may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "Canrenone may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Torasemide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "Methyclothiazide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Chlorthalidone may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00421",
                        "description": "Spironolactone may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Bendroflumethiazide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "Benzthiazide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Cyclothiazide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Eplerenone may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Hydroflumethiazide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Chlorothiazide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Trichlormethiazide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Polythiazide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01325",
                        "description": "Quinethazone may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "Theobromine may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB02925",
                        "description": "Piretanide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08961",
                        "description": "Azosemide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "Mebutizide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Cyclopenthiazide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13989",
                        "description": "Epitizide may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "Bromotheophylline may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00260",
                        "description": "Cycloserine may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "Vinorelbine may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "Teniposide may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "Cyclophosphamide may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "Vincristine may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00649",
                        "description": "Stavudine may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "Clindamycin may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "Paclitaxel may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01294",
                        "description": "Bismuth subsalicylate may increase the neurotoxic activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01598",
                        "description": "Lithium cation may increase the neurotoxic activities of Imipenem"
                    },
                    {
                        "drugbank-id": "DB01627",
                        "description": "Lithium cation may increase the neurotoxic activities of Lincomycin"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "Lithium cation may increase the neurotoxic activities of Sodium citrate"
                    },
                    {
                        "drugbank-id": "DB09275",
                        "description": "Lithium cation may increase the neurotoxic activities of Bismuth subcitrate potassium"
                    },
                    {
                        "drugbank-id": "DB11281",
                        "description": "Lithium cation may increase the neurotoxic activities of Bismuth subcarbonate"
                    },
                    {
                        "drugbank-id": "DB11537",
                        "description": "Lithium cation may increase the neurotoxic activities of Pirlimycin"
                    },
                    {
                        "drugbank-id": "DB13209",
                        "description": "Lithium cation may increase the neurotoxic activities of Bismuth subnitrate"
                    },
                    {
                        "drugbank-id": "DB06827",
                        "description": "Lithium cation may increase the neurotoxic activities of Viomycin"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "Lithium cation may increase the neurotoxic activities of Naxitamab"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tegaserod is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The risk or severity of serotonin syndrome can be increased when Dexfenfluramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The risk or severity of serotonin syndrome can be increased when Lithium cation is combined with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB08167",
                        "description": "The risk or severity of serotonin syndrome can be increased when Lithium cation is combined with Methylthioninium"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The risk or severity of serotonin syndrome can be increased when Lithium cation is combined with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of serotonin syndrome can be increased when Lithium cation is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "The risk or severity of serotonin syndrome can be increased when Lithium cation is combined with Valproate bismuth"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The therapeutic efficacy of Lithium cation can be decreased when used in combination with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Esketamine"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00781",
                        "description": "The risk or severity of adverse effects can be increased when Lithium cation is combined with Polymyxin B"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "Baclofen may decrease the excretion rate of Lithium cation which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Lithium cation is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of QTc prolongation can be increased when Trazodone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The risk or severity of QTc prolongation can be increased when Lithium cation is combined with Entrectinib"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Pitolisant may increase the QTc prolonging activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "Lefamulin may increase the QTc prolonging activities of Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Lithium cation is combined with Cyclobenzaprine"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of serotonin syndrome can be increased when Escitalopram is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "Lithium cation may increase the QTc prolonging activities of Dronedarone"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of serotonin syndrome can be increased when Lithium cation is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "The risk or severity of QTc prolongation can be increased when Hydroxyzine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of QTc prolongation can be increased when Ziprasidone is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00994",
                        "description": "The risk or severity of nephrotoxicity can be increased when Neomycin is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of QTc prolongation can be increased when Haloperidol is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of CNS depression can be increased when Ziconotide is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of serotonin syndrome can be increased when Fluoxetine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of sedation can be increased when Lithium cation is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Lithium cation is combined with Oliceridine"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}